Microbiome is a collective genome of microorganisms that reside inside and outside of the body, ranging from pathogenic to beneficial. Microbiota hosts on a biotic as well as an abiotic body.
The Microbiome Therapies market is broadly classified on the basis of various parameters. The market has been divided based on Human, Animal and Plant species. By the type of therapies for each species classified as Microbiome Addition, Removal & Nourishment and many others, also by types of microbes- Eubacteria, Bacteria, Archae, Fungi and Virus. On the basis of diagnosis- analyzers, reagents and other solutions. The market has been split by the application areas such as Pharmaceuticals, Food & Beverage and others also by End-Users in Testing Centres, Research Labs, Farms, Medical and Food outlets and as well as based on geographical analysis.
The market is led by U.S. region, due to the growing number of startups and huge investments by ventures. The growing concern for health in Middle East and APAC regions will significantly drive the market for Microbiome Therapies in these markets. APAC region will have the fastest growing market during the forecast period as improving research facilities, concern towards various life forms and growing programs driving research in this region will drive the market.
Key market players analysed are- uBiome, Evolve BioSystems, Pivot Bio, Inocucor and many others. The advancement in medical and food technologies and continuous investments by big industry tycoons and government, and penetration of start-ups in this market, indicates better prospective in Microbiome Therapies market.